Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Current understanding of the molecular mechanisms in Parkinsons disease: Targets for potential treatments
Methods Scoping Review Approach This scoping review was conducted in accordance to the guidelines set by the Joanna Briggs Institute (JBI) [14]
No single approach suits all patients, and treatment plans should be individualised based on clinical circumstances, patient preferences, and tolerability
Development and approval of rybelsus (oral semaglutide): ushering in a new era in [PMID: 34024013] Laboratory literature summary: Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery
US$ 22.88
US$ 29.58
US$ 20.48
US$ 21.55
US$ 26.35
US$ 25.15
